Alpha Tau Medical Ltd. (NASDAQ:DRTS) Short Interest Up 7.1% in December

Alpha Tau Medical Ltd. (NASDAQ:DRTS) saw a large growth in short interest in the month of December. As of December 31st, there was short interest totalling 72,600 shares, a growth of 7.1% from the December 15th total of 67,800 shares. Approximately 0.1% of the shares of the company are sold short. Based on an average trading volume of 45,600 shares, the days-to-cover ratio is currently 1.6 days.

Wall Street Analysts Forecast Growth

Separately, HC Wainwright restated a “buy” rating and set a $9.00 target price on shares of Alpha Tau Medical in a research report on Friday, November 22nd.

Alpha Tau Medical Price Performance

Shares of Alpha Tau Medical stock traded up $0.01 during midday trading on Monday, hitting $3.91. 92,315 shares of the company were exchanged, compared to its average volume of 51,170. The firm has a market cap of $273.39 million, a P/E ratio of -9.09 and a beta of 0.80. Alpha Tau Medical has a 52 week low of $1.75 and a 52 week high of $4.08. The firm has a 50 day simple moving average of $2.99 and a 200-day simple moving average of $2.50.

About Alpha Tau Medical

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, prostate, and breast cancers; and preclinical studies for brain, hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others.